Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received ...

Global pharma major Lupin Limited (Lupin) announced that it has received United States Food and Drug Administration (FDA) approval for its Abbreviated new Drug Application (ANDA), sacubitril and ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan ...

Entresto is already approved to treat heart failure with reduced ejection fraction (HFrEF), caused by the heart muscles not pumping effectively, and has revitalised the treatment of patients with ...

So Entresto is ready to be rolled out in the US with a price tag of around $4,500 a year. Novartis has hinted at an outcomes-based pricing plan but there are no details of any scheme or how it ...

The launch of a generic version of Novartis's (NYSE:NVS) blockbuster cardiac drug Entresto has reportedly been temporarily blocked by a federal appeals court as it considers the drugmaker's ...

There are some great tablets that are priced under Rs. 20,000 in India, and this list shows you those models that are currently available in the country, with the latest launched tablet shown first.

HP is one of the world's top PC makers. The company's printers and cartridges are a also big part of its business. HP's latest mobile launch is the 11-inch Tablet PC. The tablet was launched in 22nd ...

Superman Action Tablet tas bol on sale, Thule Lithos Backpack Action Webshop on sale, TAS 102 mechanism of action compared to 5 FU Download Scientific on sale, Tas Tablet View Uses Side Effects Price ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from launching a generic version of Novartis' heart-failure drug Entresto ...